scholarly journals Remote Monitoring of CIEDs—For Both Safety, Economy and Convenience?

2021 ◽  
Vol 19 (1) ◽  
pp. 312
Author(s):  
Knut Tore Lappegård ◽  
Frode Moe
Keyword(s):  
Patient Satisfaction ◽  
Remote Monitoring ◽  
Electronic Devices ◽  
Economic Advantage ◽  
Cardiac Implantable Electronic Devices ◽  
Cardiac Devices

Cardiac implantable electronic devices such as pacemakers and defibrillators are increasingly monitored by systems transmitting information directly from the patient to the hospital. This may increase safety and patient satisfaction and also under certain circumstances represent an economic advantage. The review summarizes some of the recent research in the field of remote monitoring of cardiac devices.

scholarly journals Patient satisfaction with remote monitoring of cardiac implantable electronic devices: the Valiosa questionnaire

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Miguel A. Ruiz Díaz ◽  
◽  
Marta Egea García ◽  
Roberto Muñoz Aguilera ◽  
Xavier Viñolas Prat ◽  
...  
Keyword(s):  
Patient Satisfaction ◽  
Remote Monitoring ◽  
Electronic Devices ◽  
Cardiac Implantable Electronic Devices

scholarly journals Behavior of Vas Measures of Patient Satisfaction with Remote Monitoring of Cardiac Implantable electronic devices. The valiosa questionnaire

2016 ◽  
Vol 19 (7) ◽  
pp. A700-A701 ◽  
Author(s):  
MA Ruiz ◽  
M Egea ◽  
R Muñoz ◽  
X Viñolas ◽  
J Silvestre ◽  
...  
Keyword(s):  
Patient Satisfaction ◽  
Remote Monitoring ◽  
Electronic Devices ◽  
Cardiac Implantable Electronic Devices

Implantable cardiac devices: the utility of remote monitoring in a paediatric and CHD population

2017 ◽  
Vol 27 (S1) ◽  
pp. S143-S146 ◽  
Author(s):  
Melissa M. Olen ◽  
Brynn Dechert-Crooks
Keyword(s):  
Quality Of Life ◽  
Remote Monitoring ◽  
Electronic Devices ◽  
Cardiac Implantable Electronic Devices ◽  
Cardiac Devices ◽  
Improved Outcomes ◽  
Implantable Cardiac Devices ◽  
Reduced Costs ◽  
Modern Era

AbstractRemote monitoring in the modern era has improved outcomes for patients with cardiac implantable electronic devices. There are many advantages to remote monitoring, including improved quality of life for patients, decreased need for in-office interrogation, and secondary reduced costs. Patient safety and enhanced survival remain the most significant benefit. With most of the published literature on this topic being focussed on adults, paediatric outcomes continue to be defined. This is a review of the benefits of remote monitoring in paediatrics and in patients with CHD.

Canadian Registry of Electronic Device Outcomes: remote monitoring outcomes in the Abbott battery performance alert—a multicentre cohort

EP Europace ◽  
2021 ◽  
Author(s):  
Sharath Kumar ◽  
Jason Davis ◽  
Bernard Thibault ◽  
Iqwal Mangat ◽  
Benoit Coutu ◽  
...  
Keyword(s):  
Remote Monitoring ◽  
Primary Outcome ◽  
Electronic Device ◽  
Electronic Devices ◽  
Cardiac Resynchronization ◽  
Device Performance ◽  
Cardiac Implantable Electronic Devices ◽  
All Cause Mortality ◽  
Multicentre Cohort

Abstract Aims Cardiac implantable electronic devices with device advisories have the potential of device malfunction. Remote monitoring (RM) of devices has been suggested to allow the identification of abnormal device performance and permit early intervention. We sought to describe the outcomes of patients with and without RM in devices subject to the Abbott Premature Battery Depletion (PBD) advisory with data from a Canadian registry. Methods and results Patients with an Abbott device subject to the PBD advisory from nine implantable cardioverter defibrillator (ICD) implanting centres in Canada were included in the registry. The use of RM was identified from baseline and follow-up data in the registry. The primary outcome was detection of PBD and all-cause mortality. A total of 2666 patients were identified with a device subject to the advisory. In all, 1687 patients (63.2%) had RM at baseline. There were 487 deaths during follow-up. At a mean follow-up of 5.7 ± 0.7 years, mortality was higher in those without a remote monitor compared with RM at baseline (24.7% vs. 14.5%; P < 0.001). Pre-mature battery depletion was identified in 36 patients (2.1%) with RM vs. 7 (0.7%) without RM (P = 0.004). Time to battery replacement was significantly reduced in patients on RM (median 5 vs. 13 days, P = 0.001). Conclusion The use of RM in patients with ICD and cardiac resynchronization therapy under advisory improved detection of PBD, time to device replacement, and was associated with a reduction in all-cause mortality. The factors influencing the association with mortality are unknown and deserve further study.

scholarly journals Challenges in remote monitoring of cardiac implantable electronic devices in 2021

2021 ◽  
Author(s):  
Giovanni Malanchini ◽  
Gabriele Ferrari ◽  
Cristina Leidi ◽  
Paola Ferrari ◽  
Michele Senni ◽  
...  
Keyword(s):  
Remote Monitoring ◽  
Electronic Devices ◽  
Cardiac Implantable Electronic Devices

Results of remote follow-up and monitoring in young patients with cardiac implantable electronic devices

2015 ◽  
Vol 26 (1) ◽  
pp. 53-60 ◽  
Author(s):  
Massimo S. Silvetti ◽  
Fabio A. Saputo ◽  
Rosalinda Palmieri ◽  
Silvia Placidi ◽  
Lorenzo Santucci ◽  
...  
Keyword(s):  
Remote Monitoring ◽  
Heart Defects ◽  
Electronic Devices ◽  
Young Patients ◽  
Implantable Cardioverter Defibrillators ◽  
Wireless Devices ◽  
Cardiac Implantable Electronic Devices ◽  
System Inclusion ◽  
To Receive

AbstractBackgroundRemote monitoring is increasingly used in the follow-up of patients with cardiac implantable electronic devices. Data on paediatric populations are still lacking. The aim of our study was to follow-up young patients both in-hospital and remotely to enhance device surveillance.MethodsThis is an observational registry collecting data on consecutive patients followed-up with the CareLink system. Inclusion criteria were a Medtronic device implanted and patient’s willingness to receive CareLink. Patients were stratified according to age and presence of congenital/structural heart defects (CHD).ResultsA total of 221 patients with a device – 200 pacemakers, 19 implantable cardioverter defibrillators, and two loop recorders – were enrolled (median age of 17 years, range 1–40); 58% of patients were younger than 18 years of age and 73% had CHD. During a follow-up of 12 months (range 4–18), 1361 transmissions (8.9% unscheduled) were reviewed by technicians. Time for review was 6±2 minutes (mean±standard deviation). Missed transmissions were 10.1%. Events were documented in 45% of transmissions, with 2.7% yellow alerts and 0.6% red alerts sent by wireless devices. No significant differences were found in transmission results according to age or presence of CHD. Physicians reviewed 6.3% of transmissions, 29 patients were contacted by phone, and 12 patients underwent unscheduled in-hospital visits. The event recognition with remote monitoring occurred 76 days (range 16–150) earlier than the next scheduled in-office follow-up.ConclusionsRemote follow-up/monitoring with the CareLink system is useful to enhance device surveillance in young patients. The majority of events were not clinically relevant, and the remaining led to timely management of problems.

Sign in / Sign up

Export Citation Format

Share Document